Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVAC
3226
DELISTED
Intevac Inc
IVAC
| $1.24M | ﹤0.01% |
310,618
+23,964
| +8% | +$90.3K |
|
|
LX
3227
LexinFintech Holdings
LX
$241M
| $1.24M | ﹤0.01% |
122,925
+48,798
| +66% | +$409K |
|
3228
Angi Inc
ANGI
$196M
| $1.24M | ﹤0.01% |
77,847
+699
| +0.9% | +$11.9K |
|
3229
Riverview Bancorp
RVSB
$108M
| $1.24M | ﹤0.01% |
219,093
+9,976
| +5% | +$54.2K |
|
3230
Myomo
MYO
$56.2M
| $1.24M | ﹤0.01% |
256,650
+29,390
| +13% | +$168K |
|
|
ARTV
3231
Artiva Biotherapeutics
ARTV
$551M
| $1.23M | ﹤0.01% |
410,457
+94,699
| +30% | +$511K |
|
|
AISP
3232
Airship AI Holdings
AISP
$71.3M
| $1.23M | ﹤0.01% |
318,668
+77,976
| +32% | +$362K |
|
3233
Sutro Biopharma
STRO
$421M
| $1.23M | ﹤0.01% |
188,927
+3,525
| +2% | +$55.5K |
|
3234
Indivior Pharmaceuticals
INDV
$4.58B
| $1.23M | ﹤0.01% |
128,976
+92
| +0.1% | +$967 |
|
|
SFBC
3235
Sound Financial Bancorp
SFBC
$111M
| $1.23M | ﹤0.01% |
24,446
+594
| +2% | +$30.7K |
|
3236
Vera Bradley
VRA
$98.7M
| $1.22M | ﹤0.01% |
543,890
-7,385
| -1% | -$23.9K |
|
3237
ECB Bancorp
ECBK
$181M
| $1.22M | ﹤0.01% |
80,525
+2,507
| +3% | +$36.3K |
|
3238
Zevia
ZVIA
$111M
| $1.21M | ﹤0.01% |
560,742
+21,090
| +4% | +$69K |
|
3239
TriSalus Life Sciences
TLSI
$345M
| $1.21M | ﹤0.01% |
219,424
+15,287
| +7% | +$81.4K |
|
|
BLUE
3240
DELISTED
bluebird bio
BLUE
| $1.2M | ﹤0.01% |
246,117
+12,603
| +5% | +$75.8K |
|
|
PHX
3241
DELISTED
PHX Minerals
PHX
| $1.2M | ﹤0.01% |
303,524
+8,023
| +3% | +$31.9K |
|
3242
Energy Services of America
ESOA
$292M
| $1.2M | ﹤0.01% |
126,640
+5,065
| +4% | +$55.2K |
|
3243
DiaMedica Therapeutics
DMAC
$364M
| $1.2M | ﹤0.01% |
315,741
+9,990
| +3% | +$57.1K |
|
3244
BK Technologies
BKTI
$291M
| $1.19M | ﹤0.01% |
30,457
+793
| +3% | +$25.1K |
|
|
CHMI
3245
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
| $1.19M | ﹤0.01% |
361,926
+22,322
| +7% | +$74.1K |
|
3246
Finward Bancorp
FNWD
$193M
| $1.19M | ﹤0.01% |
40,891
+2,298
| +6% | +$63.2K |
|
3247
Neuronetics
STIM
$166M
| $1.19M | ﹤0.01% |
322,777
+8,701
| +3% | +$31.8K |
|
|
LFT
3248
Lument Finance Trust
LFT
$36.6M
| $1.19M | ﹤0.01% |
454,516
+10,815
| +2% | +$28.9K |
|
|
CDTX
3249
DELISTED
Cidara Therapeutics
CDTX
| $1.18M | ﹤0.01% |
54,983
+1,915
| +4% | +$42.5K |
|
3250
dLocal
DLO
$4.24B
| $1.18M | ﹤0.01% |
141,547
+3,475
| +3% | +$39.1K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.